{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:13:04Z","timestamp":1787069584878,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,7]]},"DOI":"10.7759\/cureus.51794","type":"journal-article","created":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T10:40:40Z","timestamp":1704624040000},"source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of the Use of Highly Concentrated Autologous Platelet-Rich Plasma and Platelet-Rich Fibrin Membrane to Improve the Outcome in the Management of Severe Dry Eye Disease, Corneal Neurotrophic Ulcer and Corneal Burn"],"prefix":"10.7759","author":[{"given":"Aaliouet","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Telandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abouddihaj","family":"Barguigua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"K\u00f6rber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification report","volume":"15","author":"Craig JP","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al.. TFOS DEWS II Definition and Classification report. Ocul Surf. 2017, 15:276-83. 10.1016\/j.jtos.2017.05.008","journal-title":"Ocul Surf"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.10.044","article-title":"Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers","volume":"114","author":"Alio JL","year":"2007","unstructured":"Alio JL, Abad M, Artola A, Rodriguez-Prats JL, Pastor S, Ruiz-Colecha J. Use of autologous platelet-rich plasma in the treatment of dormant corneal ulcers. Ophthalmology. 2007, 114:1286-93.e1. 10.1016\/j.ophtha.2006.10.044","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000169","article-title":"Eye platelet-rich plasma in the treatment of ocular surface disorders","volume":"26","author":"Alio JL","year":"2015","unstructured":"Alio JL, Rodriguez AE, Wr\u00f3belDudzi\u0144ska D. Eye platelet-rich plasma in the treatment of ocular surface disorders. Curr Opin Ophthalmol. 2015, 26:325-32. 10.1097\/ICU.0000000000000169","journal-title":"Curr Opin Ophthalmol"},{"key":"ref4","article-title":"Dry eye disease results in an imbalance of neuropeptides and neurotrophins in the cornea and trigeminal ganglion","volume":"62","author":"Flavia L","year":"2021","unstructured":"Flavia L, Victor GS, Brendan K, Deshea LH, Pedram H. Dry eye disease results in an imbalance of neuropeptides and neurotrophins in the cornea and trigeminal ganglion. Invest Ophthalmol Vis Sci. 2021, 62:1319.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-8445","article-title":"Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves","volume":"53","author":"Namavari A","year":"2012","unstructured":"Namavari A, Chaudhary S, Chang JH, et al.. Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves. Invest Ophthalmol Vis Sci. 2012, 53:732-40. 10.1167\/iovs.11-8445","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31820d86d6","article-title":"Efficacy of plasma rich in growth factors for the treatment of dry eye","volume":"30","author":"L\u00f3pez-Plandolit S","year":"2011","unstructured":"L\u00f3pez-Plandolit S, Morales MC, Freire V, Grau AE, Dur\u00e1n JA. Efficacy of plasma rich in growth factors for the treatment of dry eye. Cornea. 2011, 30:1312-7. 10.1097\/ICO.0b013e31820d86d6","journal-title":"Cornea"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.21608\/ejhm.2019.42651","article-title":"Assessment of autologous (platelet-rich-plasma) as a monotherapy for treatment of dry eye disease","volume":"76","author":"Mahmoud Wahdan M","year":"2019","unstructured":"Mahmoud Wahdan M, Mohamed-Aly Ibrahim M, Farag Abdelsalam Elaraby M. Assessment of autologous (platelet-rich-plasma) as a monotherapy for treatment of dry eye disease. Egypt J Hosp Med. 2019, 76:4092-8. 10.21608\/ejhm.2019.42651","journal-title":"Egypt J Hosp Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(00)00163-9","article-title":"Topical treatment with nerve growth factor for neurotrophic keratitis","volume":"107","author":"Bonini S","year":"2000","unstructured":"Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology. 2000, 107:1347-52. 10.1016\/s0161-6420(00)00163-9","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.10.019","article-title":"Autologous serum application in the treatment of neurotrophic keratopathy","volume":"111","author":"Matsumoto Y","year":"2004","unstructured":"Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, Tsubota K. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004, 111:1115-20. 10.1016\/j.ophtha.2003.10.019","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000759","article-title":"Matrix regeneration therapy: a case series of corneal neurotrophic ulcers","volume":"35","author":"Arvola RP","year":"2016","unstructured":"Arvola RP, Robciuc A, Holopainen JM. Matrix regeneration therapy: a case series of corneal neurotrophic ulcers. Cornea. 2016, 35:451-5. 10.1097\/ICO.0000000000000759","journal-title":"Cornea"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.2474","article-title":"Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study","volume":"131","author":"Alio JL","year":"2013","unstructured":"Alio JL, Rodriguez AE, Martinez LM, Rio AL. Autologous fibrin membrane combined with solid platelet-rich plasma in the management of perforated corneal ulcers: a pilot study. JAMA Ophthalmol. 2013, 131:745-51. 10.1001\/jamaophthalmol.2013.2474","journal-title":"JAMA Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.641265","article-title":"Corneal ulcer in dogs and cats: novel clinical application of regenerative therapy using subconjunctival injection of autologous platelet-rich plasma","volume":"8","author":"Farghali HA","year":"2021","unstructured":"Farghali HA, AbdElKader NA, AbuBakr HO, Ramadan ES, Khattab MS, Salem NY, Emam IA. Corneal ulcer in dogs and cats: novel clinical application of regenerative therapy using subconjunctival injection of autologous platelet-rich plasma. Front Vet Sci. 2021, 8:641265. 10.3389\/fvets.2021.641265","journal-title":"Front Vet Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100838","article-title":"Autologous platelet-rich plasma in the treatment of refractory corneal ulcers: a case report","volume":"20","author":"Rechichi M","year":"2020","unstructured":"Rechichi M, Ferrise M, Romano F, Gallelli L, Toschi V, Dominijanni A, Meduri A. Autologous platelet-rich plasma in the treatment of refractory corneal ulcers: a case report. Am J Ophthalmol Case Rep. 2020, 20:100838. 10.1016\/j.ajoc.2020.100838","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2017.109","article-title":"A novel graft option after pterygium excision: platelet-rich fibrin for conjunctivoplasty","volume":"31","author":"Cakmak HB","year":"2017","unstructured":"Cakmak HB, Dereli Can G, Can ME, Cagil N. A novel graft option after pterygium excision: platelet-rich fibrin for conjunctivoplasty. Eye (Lond). 2017, 31:1606-12. 10.1038\/eye.2017.109","journal-title":"Eye (Lond)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S265701","article-title":"Human platelets and derived products in treating ocular surface diseases - a systematic review","volume":"14","author":"You J","year":"2020","unstructured":"You J, Hodge C, Hoque M, Petsoglou C, Sutton G. Human platelets and derived products in treating ocular surface diseases - a systematic review. Clin Ophthalmol. 2020, 14:3195-210. 10.2147\/OPTH.S265701","journal-title":"Clin Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000587","article-title":"Potential new modes of treatment of neurotrophic keratopathy","volume":"34","author":"Yanai R","year":"2015","unstructured":"Yanai R, Nishida T, Chikama T, Morishige N, Yamada N, Sonoda KH. Potential new modes of treatment of neurotrophic keratopathy. Cornea. 2015, 34:S121-7. 10.1097\/ICO.0000000000000587","journal-title":"Cornea"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-017-0100-z","article-title":"Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study","volume":"6","author":"Alio JL","year":"2017","unstructured":"Alio JL, Rodriguez AE, Ferreira-Oliveira R, Wr\u00f3bel-Dudzi\u0144ska D, Abdelghany AA. Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study. Ophthalmol Ther. 2017, 6:285-93. 10.1007\/s40123-017-0100-z","journal-title":"Ophthalmol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3182114661","article-title":"Topical autologous platelet-rich plasma eyedrops for acute corneal chemical injury","volume":"31","author":"Panda A","year":"2012","unstructured":"Panda A, Jain M, Vanathi M, Velpandian T, Khokhar S, Dada T. Topical autologous platelet-rich plasma eyedrops for acute corneal chemical injury. Cornea. 2012, 31:989-93. 10.1097\/ICO.0b013e3182114661","journal-title":"Cornea"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000439280","article-title":"Autologous plasma rich in growth factors eyedrops in refractory cases of ocular surface disorders","volume":"55","author":"Merayo-Lloves J","year":"2015","unstructured":"Merayo-Lloves J, Sanchez RM, Riestra AC, Anitua E, Bego\u00f1a L, Orive G, Fernandez-Vega L. Autologous plasma rich in growth factors eyedrops in refractory cases of ocular surface disorders. Ophthalmic Res. 2015, 55:53-61. 10.1159\/000439280","journal-title":"Ophthalmic Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/143645-evaluation-of-the-use-of-highly-concentrated-autologous-platelet-rich-plasma-and-platelet-rich-fibrin-membrane-to-improve-the-outcome-in-the-management-of-severe-dry-eye-disease-corneal-neurotrophic-ulcer-and-corneal-burn","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:16:23Z","timestamp":1707491783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/143645-evaluation-of-the-use-of-highly-concentrated-autologous-platelet-rich-plasma-and-platelet-rich-fibrin-membrane-to-improve-the-outcome-in-the-management-of-severe-dry-eye-disease-corneal-neurotrophic-ulcer-and-corneal-burn"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,7]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.51794","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,7]]}}}